Massachusetts Financial Services
MCRB icon

Massachusetts Financial Services’s Seres Therapeutics MCRB Stock Holding History

Massachusetts Financial Services’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,394
Closed -$683K – 949
2020
Q4 		$683K Buy
+1,394
New +$816K ﹤0.01% 825
2016
Q3 		– Sell
-9,483
Closed -$5.51M – 869
2016
Q2 		$5.51M Buy
9,483
+2,558
+37% +$1.5M ﹤0.01% 641
2016
Q1 		$3.68M Buy
6,925
+87
+1% +$45.4K ﹤0.01% 667
2015
Q4 		$4.8M Buy
6,838
+1,788
+35% +$1.18M ﹤0.01% 657
2015
Q3 		$2.99M Sell
5,050
-3
-0.1% -$2.45K ﹤0.01% 701
2015
Q2 		$4.19M Buy
+5,053
New +$4.41M ﹤0.01% 688

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services's MCRB Position: Q1 2021 in Review

Massachusetts Financial Services sold out of Seres Therapeutics (MCRB) in Q1 2021, closing a stake of 1,394 shares — an estimated $683K sold.

Massachusetts Financial Services first reported a position in MCRB in Q2 2015 and held it in 6 quarters. The position peaked at $5.51M in Q2 2016. 152 funds tracked by Wall St. Rank hold MCRB as of Q1 2021.

  • Massachusetts Financial Services reported no remaining Seres Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 1,394 Seres Therapeutics shares in Q1 2021, an estimated $683K.
  • Massachusetts Financial Services first reported a position in Seres Therapeutics in Q2 2015 and held it in 6 quarters.
  • Massachusetts Financial Services's Seres Therapeutics position peaked at $5.51M in Q2 2016.
  • 152 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2021.

Based on Massachusetts Financial Services's 13F filing for Q1 2021, filed 13 May 2021.